This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Is Tenet Healthcare (THC) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Will Select Medical's Solid Run in 2019 Sustain in 2020?
by Zacks Equity Research
Acquisitions, partnerships and growth in admissions to drive Select Medical's (SEM) performance in 2020.
Community Health Lags Industry YTD: Will it Reverse in 2020?
by Zacks Equity Research
Backed by lower expenses, debt repayment and business streamlining, Community Health (CYH) holds enough potential to grow in 2020.
Tenet Healthcare to Divest Units for Streamlining Operations
by Zacks Equity Research
Tenet Healthcare (THC) to sell its Memphis area units for clearing its debt and focusing on core business.
Tenet Healthcare Soars 117.1% YTD: Will Growth Continue?
by Zacks Equity Research
Tenet Healthcare's (THC) partnerships and acquisitions are likely to continue boosting its revenue base, which in turn, might perk up its share price.
5 ETFs & Stocks to Profit From One-Year High U.S. Inflation
by Sanghamitra Saha
The annual U.S. inflation for the month of November beat expectations and put these ETFs and stocks in focus.
Tenet Healthcare (THC) Is Up 10.34% in One Week: What You Should Know
by Zacks Equity Research
Does Tenet Healthcare (THC) have what it takes to be a top stock pick for momentum investors? Let's find out.
Is Tenet Healthcare (THC) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Tenet (THC) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Tenet (THC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
5 Discounted PEG Stocks for GARP Investors
by Urmimala Biswas
Although PEG is categorized under value investing, it follows the principles of both growth and value investing.
Why Is Tenet (THC) Up 17.7% Since Last Earnings Report?
by Zacks Equity Research
Tenet (THC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Top-Ranked ETFs & Stocks to Feast on Thanksgiving and After
by Sanghamitra Saha
Current market optimism, trade developments, upbeat oil prices and easing growth tensions are pointing toward a solid year-end rally. Play these top-ranked ETFs and stocks.
Zacks.com featured highlights include: Care.com, Tenet, Fortinet, Navient and SPS
by Zacks Equity Research
Zacks.com featured highlights include: Care.com, Tenet, Fortinet, Navient and SPS
5 Top Stocks Set to Register Earnings Beat
by Sanghamitra Saha
These top-ranked stocks are likely to beat on bottom line in their next releases.
Will Tenet Healthcare Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Tenet Healthcare.
MEDNAX (MD) Ties Up With Homestead to Expand in Florida
by Zacks Equity Research
MEDNAX (MD) collaborates with Associated Pediatricians of Homestead to provide clinical services and expand presence in Florida.
The Zacks Analyst Blog Highlights: Amedisys, DaVita, Tenet and Hanger
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Amedisys, DaVita, Tenet and Hanger
4 Healthcare Stocks to Gain From Stellar Q3 Earnings
by Manaswita Ghosh Dutta
Prominent activities in the healthcare sector are pushing the sector ahead this quarter.
3 Best Stocks for Richly Priced Markets
by John Blank
Yes. These are U.S. listed stocks.
Moving Average Crossover Alert: Tenet Healthcare
by Zacks Equity Research
Tenet Healthcare Corporation (THC) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
Tenet (THC) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Tenet (THC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Are Investors Undervaluing Tenet Healthcare (THC) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Healthcare Stocks in Focus on Price Transparency Rule
by Sapna Bagaria
Hospital stocks gain from a less-than-expected strict price transparency rule and health insurers' optimism on a likely rise in profitability from a low-cost plan.
MEDNAX's Ratings Get Affirmed by Moody's, Outlook Negative
by Zacks Equity Research
MEDNAX (MD) receives rating affirmations from Moody's. However, the outlook is changed to negative.
Zacks.com featured highlights include: Care.com, Tenet Healthcare, Fortinet, Navient and SPS Commerce
by Zacks Equity Research
Zacks.com featured highlights include: Care.com, Tenet Healthcare, Fortinet, Navient and SPS Commerce